Posted by Michael Wonder on 28 Mar 2024
IntraBio announces US FDA accepts new dug application for IB1001 for the treatment of Niemann-Pick disease type C
26 March 2024 - PDUFA date set for 24 September 2024.
IntraBio today announced that the US FDA has accepted its new drug application for IB1001 for the treatment of Niemann-Pick disease type C.
Read IntraBio press release
Posted by:
Michael Wonder